Page 115 - Eshre Final Programme 2015

TUESDAY 16 JUNE 2015
17:00 - 18:00 Lisbon
Selected oral communications: Session 49: Reproductive endocrinology
Chairman: L.C. Morin - Papunen (Finland) Chairman: A.P. Fernandes Soares (Portugal)
17:00 O-182
17:15 O-183
17:30 O-184
17:45 O-185
The usefulness of intrauterine hCG administration prior to blastocyst transfer in
IVF-patients >= 38 years.
B. Wirleitner1, M. Schuff1, P. Vanderzwalmen2, A. Stecher1, L. Hradeck?3, T. Kohoutek3, N.H. Zech1
1IVF-Centers Prof. Zech, Bregenz, Austria
2Centre Hospitalier Inter Régional Edith Cavell (CHIREC), Braine-l’Alleud, Belgium 3IVF-Centers Prof. Zech, Pilsen, Czech Republic
The optimal dose of medroxyprogesterone acetate (MPA) to prevent premature LH surge during controlled ovarian hyperstimulation in normal ovulatory women.
J. Dong1, Q. Chen1, A. Ai1, R. Cai1, Y. Fu1, Y. Wang1, H. Tian1, Q. Hong1, Q. Lyv1, Y. Kuang1
1Shanghai Ninth People's Hospital Shanghai Jiaotong University School of Medicine, Department of Assisted Reproduction, Shanghai, China
Effect of Dehydroepiandrosterone (DHEA) on ovine intra-follicular response prior and after controlled ovarian stimulation
A. Narkwichean1, K. Jayaprakasan2, W.E. Maalouf1, C. Pincott-Allen1, B.K. Campbell1
1University of Nottingham, Division of Child Health Obstetrics and Gynaecology, Nottingham, United Kingdom
2Royal Derby Hospital, Reproductive Medicine and Fertility Unit, Derby, United Kingdom
Ovarian Hyperstimulation Syndrome, Pregnancy, Live Birth and IVF Cycle Failure by Risk Category
P. Devroey1, P. Humaidan2, K. Gordon3, D. Gates4, B. Stegmann3
1Centre for Reproductive Medicine Universitair Ziekenhuis Brussel, Fertility, Brussels, Belgium 2The Fertility Clinic, Fertility, Skive, Denmark
3Merck & Co. Inc., Women's Health, Kenilworth, U.S.A.
4Merck & Co. Inc., Statistics, Kenilworth, U.S.A.
FINAL PROGRAMME I LISBON, PORTUGAL – 14 TO 17 JUNE 2015 115
SCIENTIFIC PROGRAMME TUESDAY, 16 JUNE